ARS Pharmaceuticals' neffy, a needle-free nasal spray for Type I allergic reactions, received early FDA approval, driving a 120% YTD share price increase. Neffy addresses a significant unmet need, ...
The inclusion of neffy on Express Scripts’ Commercial National Formularies significantly expands access to millions of commercially insured patients, improving availability of life-saving allergy ...
Good day and welcome to the ARS Pharmaceuticals' neffy (epinephrine nasal spray) FDA Approval Conference call. At this time, all participants are in listen-only mode. After the speakers’ presentation, ...
Neffy is a brand name for a new way to administer epinephrine to counter systemic allergic reactions to things such as peanuts, and the extreme form of reaction where you can’t breathe called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results